Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
30.84
-0.09 (-0.29%)
Dec 5, 2025, 4:00 PM EST - Market closed
Oruka Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 |
| Net Income | -109.24 | -91.34 |
| Depreciation & Amortization | 0.07 | 0.03 |
| Loss (Gain) From Sale of Investments | -6.79 | -2.45 |
| Stock-Based Compensation | 26.63 | 16.28 |
| Other Operating Activities | 0.53 | 1.74 |
| Change in Accounts Payable | -4.9 | 10.35 |
| Change in Other Net Operating Assets | 4.01 | 2.3 |
| Operating Cash Flow | -89.69 | -63.09 |
| Capital Expenditures | -0.18 | -0.21 |
| Investment in Securities | -434.51 | -359.93 |
| Investing Cash Flow | -434.69 | -360.14 |
| Total Debt Issued | 2.27 | 27.25 |
| Net Debt Issued (Repaid) | 2.27 | 27.25 |
| Issuance of Common Stock | 207.37 | 454.57 |
| Other Financing Activities | 0.45 | 5.39 |
| Financing Cash Flow | 210.36 | 490.41 |
| Net Cash Flow | -314.02 | 67.17 |
| Free Cash Flow | -89.87 | -63.3 |
| Free Cash Flow Per Share | -2.09 | -3.77 |
| Change in Working Capital | -0.89 | 12.64 |
Source: S&P Capital IQ. Standard template.
Financial Sources.